Diabetes medication(s)-Non-insulin oral drugs Posts on Medivizor
Navigation Menu

Diabetes medication(s)-Non-insulin oral drugs Posts on Medivizor

Evaluating the safety and effectiveness of polyethylene glycol loxenatide in patients with T2D

Evaluating the safety and effectiveness of polyethylene glycol loxenatide in patients with T2D

Posted by on Sep 20, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study examined the effectiveness and risks of polyethylene glycol loxenatide (PEX168) as an add-on to metformin (Glucophage) therapy in patients with type 2 diabetes (T2D). It found that PEX168 is safe and works effectively in improving the blood sugar levels in these patients. Some background T2D is a...

Read More

Evaluating combination therapy versus metformin only for patients with Type 2 diabetes

Posted by on Nov 13, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated whether adding vildagliptin (Galvus) to metformin (Glucophage) could improve the duration of blood glucose control for patients with newly diagnosed Type 2 Diabetes (T2D). The authors found that this treatment combination improved long-term blood glucose control for these patients. Some background...

Read More

Is IDegLira more effective than degludec or liraglutide alone for treating uncontrolled Type 2 diabetes?

Posted by on Sep 16, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study compared IDegLira (Xultophy) to insulin degludec (Tresiba) or liraglutide (Victoza) alone in patients with uncontrolled Type 2 diabetes (T2D). The authors concluded that combined IDegLira was more effective and had fewer side effects than either insulin medication alone. Some background One of the main...

Read More

Is IDegLira more effective than standard insulin for patients with Type 2 diabetes?

Posted by on Sep 4, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study compared insulin degludec/liraglutide (IDegLira) to standard insulin in patients with uncontrolled Type 2 diabetes (T2D).  The authors concluded that IDegLira improved patient compliance to treatment and reduced treatment-related stress compared to conventional insulin. Some background One of the main goals of treatment...

Read More

Can nutritional supplements help reduce hypoglycemia in patients with Type 2 diabetes?

Posted by on Sep 1, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study examined if nutritional supplements can reduce the rate of hypoglycemia in patients with Type 2 diabetes (T2D). This study concluded that these supplements helped reduce hypoglycemia and lowered mortality risk for these patients. Some background Treatment for T2D, such as insulin, can cause blood sugar levels to...

Read More

Bexagliflozin for patients with type 2 diabetes

Posted by on Aug 20, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study wanted to evaluate the safety and effectiveness of bexagliflozin in patients with type 2 diabetes (T2D). The study found that this treatment was safe and significantly improved the outcomes of these patients. Some background Bexagliflozin is a new medication for treating T2D. It is part of a larger class of...

Read More

Weight management programme led by family doctors for reversing type 2 diabetes

Posted by on May 11, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to assess the remission of type 2 diabetes (T2D) during a family doctor-led weight management programme. The main finding of the study was that after 2 years of the programme more than one-third of patients had reversed their T2D. Some background The number of people with T2D is increasing. One factor is the...

Read More

Looking for patients with type 2 diabetes to test new treatment BTI320

Posted by on Feb 17, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study is the test the effectiveness of new drug BTI320 on blood glucose control in type 2 diabetes (T2D). The main outcome to be measured will be a change in blood glucose 2 hours after meals. This study is being carried out in the United States. The details The number of patients with T2D is constantly on the rise....

Read More

How safe and effective is ertugliflozin in patients with type 2 diabetes?

Posted by on Feb 9, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to evaluate how safe and effective ertugliflozin (Steglatro) is in patients with type 2 diabetes (T2D) that is not controlled well with metformin (Glucophage). The study found that ertugliflozin is safe and improved blood glucose control, body weight, and blood pressure in these patients. Some background...

Read More

Evaluating sitagliptin in combination with pre-mixed insulin for poorly controlled Type 2 diabetes

Posted by on Oct 9, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the safety and effectiveness of adding sitagliptin (Januvia) to treatment with pre-mixed insulin in patients with poorly controlled Type 2 diabetes (T2D). This study concluded that sitagliptin was well-tolerated and significantly improved glycemic (blood sugar) control in these patients. Some background As...

Read More

Evaluating the risk of genital infections with SGLT2 inhibitors for Type 2 diabetes

Posted by on Sep 21, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the risk of genital infections in patients with Type 2 diabetes (T2D) treated with SGLT2 (sodium-glucose cotransporter 2) inhibitors. This study concluded that this therapy was associated with a 3-fold higher risk of genital infections in these patients. Some background SGLT2 inhibitors help the kidneys remove...

Read More